ArticleCell stem cell2010
Hooking up with Oct4.
Article in Cell stem cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 18 citations in OpenAlex.
- Transcription factor dynamics in plants: Insights and technologies for in vivo imaging.Plant physiology · 2022Review
- O-GlcNAc cycling: a link between metabolism and chronic disease.Annual review of nutrition · 2013Review
- Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation.Nature reviews. Molecular cell biology · 2012Review
- Oct4 links multiple epigenetic pathways to the pluripotency network.Cell research · 2012Article
- Combinatorial binding in human and mouse embryonic stem cells identifies conserved enhancers active in early embryonic development.PLoS computational biology · 2011Article
- Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells.Proceedings of the National Academy of Sciences of the United States of America · 2011Article
- In silico tandem affinity purification refines an Oct4 interaction list.Stem cell research & therapy · 2011Article
- Embryonic stem cells: protein interaction networks.Biomolecular concepts · 2011Article
- Role of Oct4 in maintaining and regaining stem cell pluripotency.Stem cell research & therapy · 2010Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transcription factor Oct4 plays a central role in controlling the undifferentiated state of embryonic and induced pluripotent stem cells. Two complementary papers in this issue of Cell Stem Cell describe the extended network of proteins that interact with Oct4. Together, these studies broaden our understanding of the control of pluripotency.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.